The Disrupted-in-Schizophrenia 1 (DISC1) gene and negative symptoms in schizophrenia are both implicated in neurodevelopmental abnormalities. However, their relationship remains unclear. Thus, this study aimed to compare plasma DISC1 levels and negative symptoms severity between first-episode schizophrenia (FDS) patients and healthy controls (HCs), and examine their association.
Product: Human Disrupted in schizophrenia 1 protein (DISC1) ELISA Kit
Pub Date:2026-05-01 IF: 3.500
Molecular biomarkers for glaucoma remain elusive. Neural-derived extracellular vesicles (NDEVs) offer diagnostic potential for neurodegenerative disorders. The aim of this study was to isolate NDEVs from the peripheral blood of patients with primary open-angle glaucoma (POAG) and investigate molecular alterations.
Product: Human Glial fibrillary acidic protein (GFAP) ELISA Kit Human Alpha-synuclein (SNCA) ELISA Kit Human Mu-crystallin homolog (CRYM) ELISA Kit Human Retinaldehyde-binding protein 1 (RLBP1) ELISA Kit
Pub Date:2026-04-30 IF: 9.700
Orotic acid (OA) is known to promote cell proliferation and influence triglyceride (TG) and protein metabolism in several animal species and cell types.
Product: Sheep Beta-casein (CSN2) ELISA Kit
Pub Date:2026-04-18 IF: 3.100
Elevated active glucocorticoids (GCs) are implicated in skin barrier dysfunction, notably in aging and diabetes. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) converts inactive GCs to active forms, potentially exacerbating this dysfunction.
Product: Mouse Corticosteroid 11-beta-dehydrogenase isozyme 1 (HSD11B1) ELISA Kit
Pub Date:2026-04-14 IF: 1.300
Fibroblast growth factor 17 (FGF17) is implicated in neurodevelopment and synaptic function, yet its role in motivation remains unclear. This study compared serum FGF17 levels (measured using ELISA) between 74 patients with major depressive disorder (MDD) and 72 healthy controls (HCs), and examined its relationship with negative symptoms measured by the Motivation and Pleasure (MAP) and Expression (EXP) subscales of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Product: Human Fibroblast growth factor 17 (FGF17) ELISA Kit
Pub Date:2026-04-07 IF: 1.700
The blood-brain barrier (BBB) is essential for maintaining the homeostasis of the central nervous system. However, the processes of BBB formation in humans remain unclear. Here, using single-cell spatiotemporal transcriptomics, we investigate human BBB development from 6 to 21 gestational weeks (GWs) and observe widespread expression of BBB-specific transporters in all brain-endothelial subclusters during development.
Product: Human Platelet-derived growth factor D (PDGFD) ELISA Kit
Pub Date:2026-03-23 IF: 25.269